News | September 25, 2013

Study Assesses Use of Fingerstick Blood Sample With i-STAT Point-of-Care Troponin Test Device

Venipuncture still the gold standard in cardiac care

Loyola, Loyola Health, Loyola Medical Center

September 25, 2013 — Researchers have determined that fingerstick cardiac troponin I assay testing using the point-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term.

The study was funded by the department of emergency medicine, Loyola University Medical Center and was published in the American Journal of Emergency Medicine. The study was conducted by Devin Loewenstein, BS, Christine Stake, MA and Mark Cichon, DO of Loyola University Chicago, department of emergency medicine.

“Cardiac troponin assays commonly exceed one hour while point-of-care testing can be completed in minutes by basic life support personnel,” said Cichon, who is chair of the emergency medicine department at Loyola. “When patients present complaining of chest pain, time can be critical to achieving positive outcomes, so Loyola was very keen to test this timesaving process.” Currently Loyola is the only academic medical center in Chicago to utilize the i-STAT device.

Conducted in the Loyola Level 1 trauma center emergency department from June to August 2011, fingerstick blood samples were collected from consenting patients for whom standard-of-care venipuncture POC troponin (POCT) testing had been ordered as part of their workup. Cardiac tropnin (cTnl) assays were performed using the i-STAT I device.

Eighty-nine cTnl levels were measured by both fingerstick and standard venipuncture. “While fingerstick testing was not accurate enough to solely determine the exact troponin level, it is accurate in qualifying tropnonin levels as negative, borderline or positive which is clinical information that may guide critical decision making,” said Cichon, who is on the board of directors of the Illinois College of Emergency Physicians (ICEP).

Cichon has served as division director for Loyola Emergency Medicine for the past 16 years. He has instituted several innovative programs to improve care for critically ill patients, including the heart attack rapid response team, telemedicine stroke program, sepsis blood infection program and hypothermia program.

For more information: www.newswise.com/institutions/newsroom/225/

Related Content

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
Technology | Blood Testing | October 09, 2019
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from...
Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes
News | Blood Testing | September 18, 2019
Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T...
Validation Studies Confirm High Accuracy of Novel HART AI-Driven Blood Tests
News | Blood Testing | March 19, 2019
Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven, multiple-protein...
CoaguChek XS PT Test Strips Recalled for Inaccurately Reporting High INR
News | Blood Testing | December 28, 2018
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as...
Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis
News | Blood Testing | October 26, 2018
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether...
New Noninvasive Blood Glucose Test as Effective as Finger Prick

Image courtesy of University of Missouri School of Medicine

News | Blood Testing | October 24, 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related...
Abbott Receives CE Mark for High Sensitive Troponin-I Test
News | Blood Testing | October 16, 2018
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I...
AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule
Overlay Init